BMRN vs NBIX
BioMarin Pharmaceutical vs Neurocrine Biosciences — AI-powered side-by-side comparison
| Metric | BMRN | NBIX |
|---|---|---|
| AI Score | 48 | 63 |
| Price | $59.60 | — |
| P/E Ratio | 42.56× | 25.47× |
| ROE | 0.1% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.8% | 1.0% |
| Debt / Equity | 0.23× | 0.12× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 59.1 | 45.1 |
| Beta | 0.239 | 0.386 |
| Expected Upside | +6.9% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMRN Full Analysis
NBIX Full Analysis